Statistics

Total Visits

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial77

File Visits

Downloads
36218-371.pdf30

Select a period of time:

Number of views in the range

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial35

Number of downloads in the range

Downloads
36218-371.pdf8

Views

Views
April 202510
May 20250
June 20250
July 202517
August 20251
September 20256
October 20251
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • April 2025
    2
  • May 2025
    3
  • June 2025
    0
  • July 2025
    1
  • August 2025
    1
  • September 2025
    0
  • October 2025
    1
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Hong Kong10
Brazil9
Barbados1
Colombia1
Egypt1
Ireland1
Mexico1
Uruguay1
 

Top countries by downloads

Downloads
United States3
Hong Kong2
 

Top cities views

Views
Hong Kong10
São Paulo2
Al Mansurah1
Bridgetown1
Campinas1
Campo Largo1
Contagem1
Dublin1
Meriden1
Montevideo1
 

Top cities by downloads

Downloads
Hong Kong2